Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Derived from transgenic multicellular eukaryote
Patent
1979-10-18
1982-07-20
Moyer, Donald B.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Derived from transgenic multicellular eukaryote
424162, A61K 3338, A61K 3304
Patent
active
043405908
ABSTRACT:
There are provided therapeutic compositions comprising certain selenium-containing compounds which exhibit therapeutic benefits in mammal hosts including humans. The selenium compounds in accordance with this invention are preferably water soluble organic or inorganic compounds containing selenium such as alkali metal selenites and selenates. Among the therapeutic benefits exhibited by these compositions are the reduction in severity from and improvements in recovery from physically induced damage to body tissue which includes damage caused by surgical incisions, lacerations and burns.
REFERENCES:
patent: 3928578 (1975-12-01), Burns et al.
Roberts, Toxicology and Applied Pharmacology 5, pp. 500-506 (1963).
Rogers' Inorganic Pharmaceutical Chemistry by Soine et al., Published by Henry Kimpton London 1957, pp. 587-588.
Cohen, L. B., Amer. J. Ophth. 38, 560-562 (1954).
Slinger et al., Arch. Dermat. and Syph, 64, pp. 41-48 (1951).
Lundy Research Laboratories, Inc.
Moyer Donald B.
LandOfFree
Method for reducing or inhibiting ecchymosis in skin tissues wit does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for reducing or inhibiting ecchymosis in skin tissues wit, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for reducing or inhibiting ecchymosis in skin tissues wit will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-250123